Exel stock price target

Feb 08, 2017 · In recent trading, shares of Exelixis Inc have crossed above the average analyst 12-month target price of $20.50, changing hands for $20.57/share.When a stock … EXEL Stock Quote | Exelixis, Inc. Research A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

OKTA Price Target | Okta Stock Forecast & Ratings See Okta price target based on 13 analysts offering 12 month price targets for Okta in the last 3 months. The average price target is $141.33 with a high forecast of $162.00 and a low forecast of $120.00. The average price target represents a 21.85% increase from the last price of $115.99. Exelixis Price Target | EXEL View Price Target for EXEL Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.

EXEL Price Target | Exelixis Stock Forecast & Ratings

The median EXEL price target (a different metric than the average or mean) was $23.0 as of 2020-02-12, the highest EXEL price target in the range was $35.0 while the lowest EXEL price target in the range was $19.0, with a standard deviation of $5.244. Get the latest Zacks research report on EXEL — FREE. 10 ETFs With Most Upside To Analyst Targets Franklin Resources Inc. Boosts Stock Position in Exelixis ... Franklin Resources Inc. increased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL) by 28.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 163,661 shares of the biotechnology company’s stock after purchasing an additional 36,571 shares during the quarter. Franklin […] Analyst Ratings for Exelixis (EXEL)

13 Mar 2020 2 analysts just weighed in on Exelixis (EXEL – Research Report) and also maintained a Buy rating on the stock with a $25.00 price target.

See Okta price target based on 13 analysts offering 12 month price targets for Okta in the last 3 months. The average price target is $141.33 with a high forecast of $162.00 and a low forecast of $120.00. The average price target represents a 21.85% increase from the last price of $115.99.

Nov 10, 2019 · Exelixis Inc. analyst estimates by MarketWatch. View EXEL revenue estimates and earnings estimates, as well as analyst recommendations.

Exelixis, Inc. Common Stock (EXEL) Stock Quotes | Nasdaq

Exelixis Inc. - NASDAQ:EXEL - Stock Quote & News - TheStreet

23 Mar 2020 The stock currently trades at $15.27 and analysts tracking its performance over the next 12 months have a consensus estimate price target of  Wednesday, March 18, 2020 11:15 AM | InvestorsObserver Analysts. Is Exelixis, Inc. (EXEL) Stock a Good Buy in Biotechnology. The 54 rating  19 Mar 2020 Looking into the profitability ratios of EXEL stock, an investor will find its Analyst's mean target price for the company is $24.54 while analysts 

Exelixis Inc. - NASDAQ:EXEL - Stock Quote & News - TheStreet View detailed financial information, real-time news, videos, quotes and analysis on Exelixis Inc. (NASDAQ:EXEL). Explore commentary on Exelixis Inc. and hear what the experts at TheStreet are EXEL:NASDAQ GS Stock Quote - Exelixis Inc - Bloomberg Markets